We’re pleased to announce that our preclinical laboratory has again earned a Full Accreditation from AAALAC International Council.

TD2 has held AAALAC accreditation since 2010, and we’re thrilled that the 2018 renewal continues that succession through 2021.

In their letter of notification, the AAALAC Council on Accreditation made special recognitions of the following features of our preclinical facility, staff and resources:

– Our administrative commitment to the program, along with the caliber of our documentation throughout it.

– The engagement of our Institutional Animal Care and Use Committee.

– The level of sanitation, cleanliness and organization in our facility.

– Our Occupational Health & Safety signage.

– Our tumor monitoring guideline.

– Our heating, ventilation and air conditioning monitoring system.

– Our storage and documentation practices for controlled substances.

We’re proud to support humane and responsible animal treatment throughout all ends of our scientific research, and we’re honored to continue this voluntary accreditation for years to come.

Want to learn more about our AAALAC-accredited preclinical lab? Ask us for a tour!

Efficient Data Management: One Way to Expedite the Clinical Development Proces

Debates on the safety and effectiveness of vaccines have captured the public’s attention recently. A vaccine is a preventative strategy for certain...

Read more +

The Clinical Trial Process Continues Amid COVID-19

It’s no secret that the top health concern on most Americans’ minds today is COVID-19 – a unprecedented disrupter like we’ve never seen...

Read more +

Technology Challenges and Trends in Clinical Trials

Cancer remains a leading cause of death among Americans with nearly two million newly diagnosed patients in 2018. As this trend continues, various...

Read more +

GET STARTED

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.